| Literature DB >> 29744485 |
Qiling Chen1, Yuanyuan Yang, Xun Lin, Wen Ma, Gui Chen, Wenliang Li, Xuefeng Wang, Zhiqiang Yu.
Abstract
Platinum(iv) prodrugs of clinically used cisplatin and oxaliplatin with two axial long lipid chains were developed for nanoparticle delivery to combat cisplatin resistance.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29744485 DOI: 10.1039/c8cc02791a
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222